Immunohistochemical analysis of tumor tissue from both HT-29 and 8305C xenografts (Table 2) revealed that, in all treated groups, the activation of caspase-3 was significantly increased, while microvascular density (CD31+ staining) was significantly reduced. The gene discussed is CASP3; the disease is neoplasm.